Gesine Meyer-Rath, MD, PhD
Research Associate Professor
Boston University School of Public Health
Dept of Global Health

MD, Freie Universität Berlin
PhD, Freie Universität Berlin




Dr Meyer-Rath is a Research Associate Professor at the Center for Global Health and Development of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV and antiretroviral treatment in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining CGHD she has worked in the Pediatrics Department of Charité University Hospital Berlin, at the World Health Organization and at the London School of Hygiene and Tropical Medicine.

Dr Meyer-Rath is currently based in Johannesburg where she works at the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between Boston University and the University of the Witwatersrand. She holds a PhD in Health Economics from the London School of Hygiene and Tropical Medicine as well as a MD/PhD in Physiology from Free University Berlin.

2010 International AIDS Society/ ANRS: Young Investigator Award


Economic Impact of HIV Policy Briefs
11/14/2019 - 10/31/2020 (PI)
Bill and Melinda Gates Foundation


Enhancing the evidence-base for HIV self-testing in young men
04/17/2018 - 03/31/2020 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates


Identifying optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa
09/01/2016 - 07/31/2017 (Subcontract PI)
Imperial College Bill & Melinda Gates




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity. Clin Infect Dis. 2020 Jul 06.View Related Profiles. PMID: 32628744; DOI: 10.1093/cid/ciaa937;
     
  2. Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa. AIDS. 2020 05 01; 34(6):883-891. PMID: 32004205
     
  3. Phillips A, Cambiano V, Johnson L, Nakagawa F, Homan R, Meyer-Rath G, Rehle T, Tanser F, Moyo S, Shahmanesh M, Castor D, Russell E, Jamieson L, Bansi-Matharu L, Shroufi A, Barnabas R, Parikh UM, Mellors JW, Revill P. Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance. J Infect Dis. 2019 Dec 18. PMID: 31851759
     
  4. Lince-Deroche N, Leuner R, Meyer-Rath G, Pillay Y, Long L. When donor funding leaves: an interrupted time-series analysis of the impact of integrating direct HIV care and treatment into public health services in a region of Johannesburg. Cost Eff Resour Alloc. 2019; 17:24.View Related Profiles. PMID: 31673249
     
  5. Girdwood S, Govender K, Long L, Miot J, Meyer-Rath G. Primary healthcare delivery models for uninsured low-income earners during the transition to National Health Insurance: Perspectives of private South African providers. S Afr Med J. 2019 Sep 30; 109(10):771-783.View Related Profiles. PMID: 31635576
     
  6. Johnson LF, van Rensburg C, Govathson C, Meyer-Rath G. Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness. Sci Rep. 2019 09 02; 9(1):12621. PMID: 31477764
     
  7. Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Wilson D, Jani I, Apollo T, Sculpher M, Hallett T, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams B, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Barnabas R, Ayles H, Meyer-Rath G, Nelson L, Johnson C, Baggaley R, Fakoya A, Jahn A, Revill P. Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis. J Int AIDS Soc. 2019 07; 22(7):e25325. PMID: 31287620
     
  8. Meyer-Rath G, van Rensburg C, Chiu C, Leuner R, Jamieson L, Cohen S. The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case. PLoS One. 2019; 14(2):e0210497. PMID: 30807573
     
  9. Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):195-205. PMID: 29916959
     
  10. Meyer-Rath G, McGillen JB, Cuadros DF, Hallett TB, Bhatt S, Wabiri N, Tanser F, Rehle T. Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning. AIDS. 2018 05 15; 32(8):957-963. PMID: 29547437
     
Showing 10 of 47 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 47 publications over 13 distinct years, with a maximum of 7 publications in 2013 and 2017

YearPublications
20031
20073
20092
20111
20126
20137
20143
20152
20164
20177
20183
20196
20202

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HIV, economic evaluation, costs, investment case, antiretroviral treatment
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Meyer-Rath's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department